Show simple item record

dc.creatorGoldstein, Nathanen
dc.creatorCarlson, Melissaen
dc.creatorLivote, Elayneen
dc.creatorKutner, Jean S.en
dc.date.accessioned2016-01-09T00:41:58Zen
dc.date.available2016-01-09T00:41:58Zen
dc.date.created2010-03-02en
dc.date.issued2010-03-02en
dc.identifierdoi:10.1059/0003-4819-152-5-201003020-00007en
dc.identifier.bibliographicCitationAnnals of Internal Medicine 2010 March 2; 152(5): 296-299en
dc.identifier.urihttp://worldcatlibraries.org/registry/gateway?version=1.0&url_ver=Z39.88-2004&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&atitle=Brief+communication:+Management+of+implantable+cardioverter-defibrillators+in+hospice:+A+nationwide+survey.&title=Annals+of+Internal+Medicine+&volume=152&issue=5&date=2010-03&au=Goldstein,+Nathan;+Carlson,+Melissa;+Livote,+Elayne;+Kutner,+Jean+S.en
dc.identifier.urihttp://dx.doi.org/10.1059/0003-4819-152-5-201003020-00007en
dc.identifier.urihttp://hdl.handle.net/10822/1023814en
dc.description.abstractBACKGROUND: Communication about the deactivation of implantable cardioverter-defibrillators (ICDs) in patients near the end of life is rare. OBJECTIVE: To determine whether hospices are admitting patients with ICDs, whether such patients are receiving shocks, and how hospices manage ICDs. DESIGN: Cross-sectional survey. SETTING: Randomly selected hospice facilities. PARTICIPANTS: 900 hospices, 414 of which responded fully. MEASUREMENTS: Frequency of admission of patients with ICDs, frequency with which patients received shocks, existence of ICD deactivation policies, and frequency of deactivation. RESULTS: 97% of hospices admitted patients with ICDs, and 58% reported that in the past year, a patient had been shocked. Only 10% of hospices had a policy that addressed deactivation. On average, 42% (95% CI, 37% to 48%) of patients with ICDs had the shocking function deactivated. LIMITATION: The study relied on the knowledge of hospice administrators. CONCLUSION: Hospices are admitting patients with ICDs, and patients are being shocked at the end of life. Ensuring that hospices have policies in place to address deactivation may improve the care for patients with these devices. The authors provide a sample deactivation policy. PRIMARY FUNDING SOURCE: National Institute of Aging and National Institute of Nursing Research.en
dc.formatArticleen
dc.languageenen
dc.sourceeweb:331251en
dc.subjectAdministratorsen
dc.subjectAgingen
dc.subjectCommunicationen
dc.subjectHospicesen
dc.subjectKnowledgeen
dc.subjectLifeen
dc.subjectNursing Researchen
dc.subjectPatientsen
dc.subjectResearchen
dc.subjectSurveyen
dc.subject.classificationQuality of Health Careen
dc.subject.classificationCare of the Dying Patienten
dc.subject.classificationProlongation of Life and Euthanasiaen
dc.titleBrief Communication: Management of Implantable Cardioverter-Defibrillators in Hospice: A Nationwide Surveyen
dc.provenanceCitation prepared by the Library and Information Services group of the Kennedy Institute of Ethics, Georgetown University for the ETHXWeb database.en
dc.provenanceCitation migrated from OpenText LiveLink Discovery Server database named EWEB hosted by the Bioethics Research Library to the DSpace collection EthxWeb hosted by DigitalGeorgetown.en


This item appears in the following Collection(s)

Show simple item record


Georgetown University Seal
©2009—2022 Bioethics Research Library
Box 571212 Washington DC 20057-1212
202.687.3885